KLK3 and pachyonychia congenita: Some 10% of PC patients have been diagnosed with locally advanced tumors, characterized by T3 or T4 (PSA < 100 ng/mL); among the patients diagnosed in the 2008–2011 period, 83% survived for 5 years [17].